MedTech Finance Services in Australia
Financial Expertise for Medical Technology and Digital Health Companies
Growwth Partners provides specialised MedTech finance services in Australia for medical device manufacturers, digital health companies, and healthcare technology innovators.
Finance for Healthcare Innovation. Compliance for Sustainable Growth.
What Our MedTech Finance Services Include
We support Australian MedTech organisations with R&D financial management, regulatory compliance, GST considerations, and investor readiness — enabling them to scale efficiently in a highly regulated environment.
R&D Tax Incentive & Grant Management
Tracking eligible R&D expenses and supporting claims under the Australian R&D Tax Incentive program.
Regulatory & Compliance Reporting
Preparing financial records aligned with regulatory requirements including those of the Therapeutic Goods Administration (TGA).
Inventory & Manufacturing Cost Management
Managing cost structures for medical devices and ensuring accurate inventory valuation across Australian operations.
Revenue Recognition
Ensuring compliance with accounting standards (AASB 15) for licensing, subscription, and milestone-based healthcare contracts.
GST Compliance & BAS Preparation
Ensuring accurate GST treatment for MedTech transactions and assisting with ATO BAS filings.
Financial Modelling & Investor Readiness
Developing investor-ready financial models to support venture capital funding and government grant applications.
CFO-Level Strategic Advisory
Providing financial leadership for scaling, commercialisation, and international expansion from Australia.
Unlike general finance services, Australian MedTech finance requires tight integration between R&D tax incentives, TGA compliance, and investor-ready reporting to sustain innovation and growth.
Who Should Use MedTech Finance Services in Australia?
Our services are suitable for:
If your Australian MedTech business struggles to answer:
Are we maximising our R&D Tax Incentive claims correctly?
Are our financial systems compliant with TGA requirements?
Do we have investor-ready financials for our next funding round?
You need specialised Australian MedTech finance leadership.
Common Financial Challenges in Australian MedTech Companies
Challenges Faced by MedTech Companies
Regulatory Compliance Requirements
Strict TGA regulatory frameworks demand accurate and audit-ready financial records.
High R&D Costs
Significant investment in research requires careful financial planning and R&D Tax Incentive tracking.
Funding and Grant Management
Managing venture capital and government grants necessitates structured, compliance-ready reporting.
Complex Manufacturing and Inventory
Medical device production involves detailed cost and inventory management across Australian facilities.
Revenue Recognition Complexity
Milestone-based and licensing agreements complicate financial reporting under AASB 15.
These challenges can delay market entry and reduce investor confidence in Australian MedTech.
What You Get With Our Services
Accurate R&D and grant financial management
Regulatory and TGA compliance-ready reporting
GST-compliant financial systems and BAS preparation
Investor-ready financial models and forecasting
Improved cash flow and working capital management
Strategic CFO-level guidance for Australian growth
Designed to support compliant, investor-ready MedTech growth in Australia
How Growwth Partners Supports MedTech Companies in Australia
Our Australian MedTech Finance services deliver control, transparency, and regulatory confidence for healthcare innovators across Sydney, Melbourne, Brisbane, and beyond.
System Implementation
- Setup and integration with Xero, MYOB, and QuickBooks
- Cloud-based financial infrastructure for Australian MedTech operations
- Integration with project management and inventory systems
R&D and Grant Tracking
- Monitor R&D expenses eligible for the Australian R&D Tax Incentive
- Track grant disbursements and AusIndustry compliance
- Accurate R&D cost capitalisation and expense allocation
Compliance Support
- Ensure TGA regulatory financial compliance
- GST compliance and BAS preparation for MedTech transactions
- ATO-compliant record keeping and audit readiness
Performance Reporting
- Deliver actionable financial KPI dashboards
- Investor-ready reporting for board and VC meetings
- Cash flow and runway forecasting models
Strategic Advisory
- Support fundraising and Australian commercialisation strategies
- Financial modelling for new product launches and TGA submissions
- CFO-led guidance for international expansion from Australia
Why MedTech Companies Choose Growwth Partners in Australia
Deep Industry Expertise in Healthcare and Medical Technology
Experience across Australian medical device, digital health, diagnostics, and biotech sectors
Regulatory Compliance Knowledge
Strong understanding of TGA regulatory requirements, R&D Tax Incentive rules, and ATO compliance obligations
Integrated Accounting and CFO Services
Seamlessly combines bookkeeping, payroll, GST compliance, and strategic CFO advisory in one engagement
Investor-Ready Financial Reporting
Board-level reports, VC-ready models, and pitch-deck financials to support Australian and international fundraising
Scalable Financial Systems
AI-enabled dashboards and cloud-based tools (Xero, MYOB) for real-time visibility as your MedTech scales
We help Australian MedTech businesses balance healthcare innovation with financial discipline and regulatory confidence.
Use Cases — Australia
See how we help Australian MedTech companies build compliant, investor-ready financial systems and scale with confidence.
Client Type
Medical Device Startup — Melbourne
Challenges
- Eligible R&D expenses not tracked for Tax Incentive claims
- No investor-ready financial model for VC fundraising
- Cash burn rate unclear to founders and board
Solution
- Implemented R&D expense tracking aligned with ATO Tax Incentive rules
- Built 3-year investor-ready financial model and scenario forecasts
- Introduced monthly burn rate and runway dashboard for board reporting
Outcome
- Maximised R&D Tax Incentive cash refund
- Successfully secured Series A VC funding
- Board-ready monthly financial reporting
- Clear runway visibility supporting confident hiring decisions
Medical Device Startup — Melbourne
Challenges
- Eligible R&D expenses not tracked for Tax Incentive claims
- No investor-ready financial model for VC fundraising
- Cash burn rate unclear to founders and board
Solution
- Implemented R&D expense tracking aligned with ATO Tax Incentive rules
- Built 3-year investor-ready financial model and scenario forecasts
- Introduced monthly burn rate and runway dashboard for board reporting
Outcome
- Maximised R&D Tax Incentive cash refund
- Successfully secured Series A VC funding
- Board-ready monthly financial reporting
- Clear runway visibility supporting confident hiring decisions
Digital Health Company — Sydney
Challenges
- GST treatment unclear across subscription and per-consult billing
- No KPI reporting tracking key telehealth metrics
- Cash flow forecasting lagging rapid nationwide expansion
Solution
- Structured GST compliance and BAS preparation across all revenue streams
- Built KPI dashboards tracking MRR, patient volume, and CAC
- Developed rolling cash flow forecast aligned to expansion milestones
Outcome
- ATO-compliant GST across all service types
- Real-time financial visibility for CEO and board
- Cash flow planning aligned to nationwide rollout
- Investor-ready metrics ahead of Series B
Diagnostics Manufacturer — Brisbane
Challenges
- Inventory cost management complex across manufacturing and distribution
- TGA compliance documentation not aligned with financial records
- Margin unclear at product and SKU level
Solution
- Built landed cost and inventory valuation model by SKU
- Aligned financial records with TGA compliance documentation requirements
- Introduced product-level margin reporting across the portfolio
Outcome
- Accurate per-unit cost and margin tracking
- TGA audit-ready financial documentation
- Improved pricing confidence across product lines
- Reduced inventory write-offs through better cost controls
International MedTech — Australian Market Entry
Challenges
- No local financial infrastructure for Australian operations
- GST registration and BAS obligations unclear
- Intercompany transactions with global HQ unstructured
Solution
- Set up Australian financial infrastructure and chart of accounts
- Managed GST registration and first BAS lodgement with ATO
- Structured intercompany billing and transfer pricing framework
Outcome
- Australian entity fully operational with compliant financials
- GST-registered and ATO-compliant from day one
- Clean intercompany accounting across global structure
- Board reporting aligned between Australian and global HQ
AI Healthcare Analytics Company — Sydney
Challenges
- Rapid scaling with no structured financial systems
- R&D Tax Incentive not claimed despite significant eligible spend
- No investor-ready dashboards for upcoming funding round
Solution
- Implemented cloud-based finance stack for scaling operations
- Identified and documented eligible R&D spend for Tax Incentive claim
- Built investor-ready dashboards with ARR, burn rate, and growth metrics
Outcome
- First R&D Tax Incentive cash refund received
- Real-time financial visibility for CEO and investors
- Monthly board-ready financial packs delivered
- Finance function ready to support Series B raise
Frequently Asked Questions
Common questions about our MedTech Finance Services in Australia
Accelerate Your MedTech Growth with Financial Expertise
Growwth Partners helps Australian MedTech companies build structured financial systems, ensure TGA and ATO compliance, and scale with confidence.